| 臺大學術典藏 |
2022-09-20T08:31:39Z |
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis
|
Chen, Mei-Jyh; Bair, Ming-Jong; Chen, Po-Yueh; Lee, Ji-Yuh; Yang, Tsung-Hua; YU-JEN FANG; Chen, Chieh-Chang; Chang, An-Ti; Hsiao, Wang-De; Yu, Jian-Jyun; Kuo, Chia-Chi; Chiu, Min-Chin; Lin, Kun-Pei; Tsai, Min-Horn; Hsu, Yao-Chun; Chou, Chu-Kuang; Chen, Chi-Yi; Lin, Jaw-Town; Lee, Yi-Chia; Wu, Ming-Shiang; Liou, Jyh-Ming |
| 臺大學術典藏 |
2022-09-20T08:29:19Z |
Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients
|
Chung, Chen-Shuan; Chen, Chieh-Chang; Chen, Kuan-Chih; YU-JEN FANG; Hsu, Wen-Feng; YEN-NIEN CHEN; Tseng, Wei-Chuang; Lin, Cheng-Kuan; Lee, Tzong-Hsi; Wang, Hsiu-Po; Wu, Yen-Wen |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
Barium appendicitis
|
YU-JEN FANG; Wang H.-P.; Ho C.-M.; Liu K.-L. |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
A rare diagnosis of right upper quadrant abdominal pain
|
Chung C.-S.; Wang H.-P.; YU-JEN FANG; Hu R.-H.; Hsiao J.-K.; Chen C.-G.H. |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter
|
Han M.-L.; Lee Y.-C.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Lin T.-L.; Lin L.-W.; Tseng P.-H.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumors
|
YU-JEN FANG; Cheng T.-Y.; Sun M.-S.; Yang C.-S.; Chen J.-H.; Liao W.-C.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
Yang S.-H.; Lin L.-W.; YU-JEN FANG; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; YU-JEN FANG; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; YU-JEN FANG; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
YU-JEN FANG; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:50Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:50Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; YU-JEN FANG; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; Liu C.-J.; Su T.-H.; YU-JEN FANG; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; YU-JEN FANG; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; Wu M.-S.; Chen C.-C.; Chen C.-C.; YU-JEN FANG; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; YU-JEN FANG; Lin J.-T.; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; YU-JEN FANG; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:47Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; YU-JEN FANG; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:47Z |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; YU-JEN FANG; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:46Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; YU-JEN FANG; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:46Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-M.; YU-JEN FANG; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; YU-JEN FANG; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:44Z |
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan
|
Chen M.-J.; YU-JEN FANG; Wu M.-S.; Chen C.-C.; Chen Y.-N.; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:44Z |
Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan
|
Yang T.-H.; YU-JEN FANG; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Chen C.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:44Z |
Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan
|
YU-JEN FANG; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; Wu M.-S.; Luo J.-C.; Liou J.-M. |
| 臺大學術典藏 |
2022-02-14T06:28:43Z |
Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles
|
Chen C.-C.; Wu W.-K.; Chang C.-M.; Panyod S.; Lu T.-P.; Liou J.-M.; YU-JEN FANG; Chuang E.Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:43Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; YU-JEN FANG; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline Results
|
Lee Y.-C.; Chiang T.-H.; Chiu H.-M.; Wu M.-S.; Yeh Y.-P.; Hsiu-Hsi Chen T.; Li-Sheng Chen S.; Ming-Fang Yen A.; Ching-Yuan Fann J.; Yueh-Hsia Chiu S.; Hsu C.-Y.; Chuang S.-L.; Chou K.-C.; Su W.-W.; Chen S.-T.; Liao C.-S.; Lin Y.-M.; Chang H.-C.; Hu T.-H.; YU-JEN FANG; Chan C.-C.; Collaborators of the Taiwan Community-Based Integrated Screening Group |
| 臺大學術典藏 |
2022-02-14T06:28:41Z |
The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double-blind, placebo-controlled, randomized trial
|
Chen M.-J.; Chen C.-C.; Huang Y.-C.; Tseng C.-C.; Hsu J.-T.; Lin Y.-F.; YU-JEN FANG; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease, Helicobacter Consortium |
| 臺大學術典藏 |
2018-09-10T15:35:03Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Yao-Chun Hsu;Lein-Ray Mo;Chi-Yang Chang;Ming-Shiang Wu;Jia-Horng Kao;Wen-Lun Wang;Tzeng-Huey Yang;Chaur-Shine Wang;Ming-Feng Chiang;Chieh-Chang Chen;Yu-Jen Fang;Hsu-Wei Hung;Chun-Ying Wu;Jaw-Town Linhsu, Yao-Chun;Mo, Lein-Ray;Chang, Chi-Yang;Wu, Ming-Shiang;Kao, Jia-Horng;Wang, Wen-Lun;Yang, Tzeng-Huey;Wang, Chaur-Shine;Chiang, Ming-Feng;Chen, Chieh-Chang;Fang, Yu-Jen;Hung, Hsu-Wei;Wu, Chun-Ying;Lin, Jaw-Town; Hsu, Yao-Chun; MING-SHIANG WU; Mo, Lein-Ray; JIA-HORNG KAO; Chang, Chi-Yang; Wu, Ming-Shiang; Wu, Ming-Shiang; Kao, Jia-Horng; Kao, Jia-Horng; Wang, Wen-Lun; Wang, Wen-Lun; Yang, Tzeng-Huey; Yang, Tzeng-Huey; Wang, Chaur-Shine; Chiang, Ming-Feng; Chiang, Ming-Feng; Chen, Chieh-Chang; Chen, Chieh-Chang; Fang, Yu-Jen; Fang, Yu-Jen; Hung, Hsu-Wei; Hung, Hsu-Wei; Wu, Chun-Ying; Wu, Chun-Ying; Lin, Jaw-Town |
| 義守大學 |
2016-11 |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
|
Jyh-Ming Liou;Chieh-Chang Chen;Chi-Yang Chang;Mei-Jyh Chen;Chien-Chuan Chen;Yu-Jen Fang;Ji-Yuh Lee;Tsung-Hua Yang;Jiing-Chyuan Luo;Jeng-Yih Wu;Tai-Cherng Liou;Wen-Hsiung Chang;Yao-Chun Hsu;Cheng-Hao Tseng;Chun-Chao Chang;Ming-Jong Bair;Tzeng-Ying Liu;Chun-Fu Hsieh;Feng-Yun Tsao;Chia-Tung Shun;Jaw-Town Lin;Yi-Chia Lee;Ming-Shiang Wu |
| 義守大學 |
2016-03 |
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial
|
Jyh-Ming Liou;Ming-Jong Bair;Chieh-Chang Chen;Yi-Chia Lee;Mei-Jyh Chen;Chien-Chuan Chen;Cheng-Hao Tseng;Yu-Jen Fang;Ji-Yuh Lee;Tsung-Hua Yang;Jiing-Chyuan Luo;Jeng-Yih Wu;Wen-Hsiung Chang;Chun-Chao Chang;Chi-Yi Chen;Po-Yueh Chen;Chia-Tung Shun;Wen-Feng Hsu;Hsu-Wei Hung;Jaw-Town Lin;Chi-Yang Chang;Ming-Shiang Wu |
| 義守大學 |
2015-10 |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Yu-Jen Fang;Jyh-Ming Liou;Chieh-Chang Chen;Ji-Yuh Lee;Yao-Chun Hsu;Mei-Jyh Chen;Ping-Huei Tseng;Chien-Chuan Chen;Chi-Yang Chang;Tsung-Hua Yang;Wen-Hsiung Chang;Jeng-Yi Wu;Hsiu-Po Wang;Jiing-Chyuan Luo;Jaw-Town Lin;Chia-Tung Shun;Ming-Shiang Wu |
| 義守大學 |
2015-05 |
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study
|
Jyh-Ming Liou;Chi-Yang Chang;Mei-Jyh Chen;Chieh-Chang Chen;Yu-Jen Fang;Ji-Yuh Lee;Jeng-Yih Wu;Jiing-Chyuan Luo;Tai-Cherng Liou;Wen-Hsiung Chang;Cheng-Hao Tseng;Chun-Ying Wu;Tsung-Hua Yang;Chun-Chao Chang;Hsiu‐Po Wang;Bor-Shyang Sheu;Jaw-Town Lin;Ming-Jong Bair;Ming-Shiang Wu |
| 義守大學 |
2013-01 |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Jyh-Ming Liou;Chieh-Chang Chen;Mei-Jyh Chen;Chien-Chuan Chen;Chi-Yang Chang;Yu-Jen Fang;Ji–Yuh Lee;Shih-Jer Hsu;Jiing-Chyuan Luo;Wen-Hsiung Chang;Yao-Chun Hsu;Cheng-Hao Tseng;Ping-Huei Tseng;Hsiu-Po Wang;Ueng-Cheng Yang;Chia-Tung Shun;Jaw-Town Lin;Yi-Chia Lee;Ming-Shiang Wu |
| 義守大學 |
2012-10 |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
|
Jyh-Ming Liou;Chieh-Chang Chen;Chi-Yang Chang;Mei-Jyh Chen;Yu-Jen Fang;Ji-Yuh Lee;Chien-Chuan Chen;Shih-Jer Hsu;Yao-Chun Hsu;Cheng-Hao Tseng;Ping-Huei Tseng;Lawrence Chang;Wen-Hsiung Chang;Hsiu-Po Wang;Chia-Tung Shun;Jeng-Yih Wu;Yi-Chia Lee;Jaw-Town Lin;Ming-Shiang Wu |
| 義守大學 |
2011-05 |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
|
Jyh-Ming Liou;Chieh-Chang Chen;Mei-Jyh Chen;Chi-Yang Chang;Yu-Jen Fang;Ji-Yuh Lee;Wang-Huei Sheng;Hsiu-Po Wang;Ming-Shiang Wu;Jaw-Town Lin |
| 國立臺灣大學 |
2008-12 |
A Novel Opto-Electromagnetic Actuator Coupled to The Tympanic Membrane
|
Lee, Chia-Fone; Shih, Chih-Hua; Yu, Jen-Fang; Chen, Jyh-Horng; Chou, Yuan-Fang; Liu, Tien-Chen |
| 國立臺灣大學 |
2008 |
A novel opto-electromagnetic actuator coupled to the tympanic membrane
|
Lee, Chia-Fone; Shih, Chih-Hua; Yu, Jen-Fang; Chen, Jyh-Horng; Chou, Yuan-Fang; Liu, Tien-Chen |
| 國立臺灣大學 |
2008 |
A Novel Opto-Electromanetic Actuator Coupled to the Tympanic Membrane
|
李家鳳; 施治華; 余仁芳; 陳志宏; 周元昉; 劉殿楨; LEE, CHIA-FENG; SHIH, CHIH-HWA; YU, JEN-FANG; CHEN, JYH-HORNG; CHOU, YUAN-FANG; LIU, TIEN-CHEN |
| 國立臺灣大學 |
2005 |
Curvature of in Vivo Human Tympanic Membrane
|
Yu, Jen-Fang; Lee, Chung-Yi; Chen, Jyh-Horng; Lien, Hsin-Chung; Lin, Ta-Te |
| 國立臺灣大學 |
2004 |
In vivo measurement of human tympanic membrane structure
|
Yu, Jen-Fang; Cheng, Yu-Che; Lee, Chung-Yi; Chen, Jyh-Horng; Lien, Hsin-Chung; Lin, Ta-Te |
| 國立臺灣大學 |
2003 |
Measurement of in vivo human tympanic membrane by MR imaging
|
Yu, Jen-Fang; Cheng, Yu-Che; Lee, Chung-Yi; Chen, Jyh-Horng; Lin, Ta-Te |
